Eli Accounts Payable from 2010 to 2024

LLY Stock  USD 748.01  1.91  0.25%   
Eli Lilly Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable is likely to outpace its year average in 2024. Accounts Payable is the amount Eli Lilly and owes to suppliers or vendors for products or services received but not yet paid for. It represents Eli Lilly's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
1989-06-30
Previous Quarter
2.9 B
Current Value
2.9 B
Quarterly Volatility
554.5 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 941.5 M, Interest Expense of 510.2 M or Total Revenue of 35.8 B, as well as many indicators such as Price To Sales Ratio of 16.15, Dividend Yield of 0.0074 or PTB Ratio of 51.15. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
  
Check out the analysis of Eli Lilly Correlation against competitors.

Latest Eli Lilly's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Eli Lilly and over the last few years. An accounting item on the balance sheet that represents Eli Lilly obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Eli Lilly are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Eli Lilly's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eli Lilly's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Eli Accounts Payable Regression Statistics

Arithmetic Mean1,466,876,000
Geometric Mean1,302,358,858
Coefficient Of Variation41.94
Mean Deviation426,808,000
Median1,349,300,000
Standard Deviation615,223,666
Sample Variance378500.2T
Range2.5B
R-Value0.88
Mean Square Error91639.9T
R-Squared0.78
Significance0.000015
Slope121,121,000
Total Sum of Squares5299002.2T

Eli Accounts Payable History

20242.7 B
20232.6 B
20221.9 B
20211.7 B
20201.6 B
20191.4 B
20181.2 B

About Eli Lilly Financial Statements

Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable2.6 B2.7 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.